Results 41 to 50 of about 13,477 (288)

ARC syndrome accompanied with glaucoma in one of two affected siblings. [PDF]

open access: yesPediatr Int
Pediatrics International, Volume 67, Issue 1, January/December 2025.
Okuno T   +4 more
europepmc   +2 more sources

Pharmacokinetics and Pharmacology of Latanoprost 0.005% without Benzalkonium Chloride Vs Latanoprost 0.005% with Benzalkonium Chloride in New Zealand White Rabbits and Beagles

open access: yesCurrent Eye Research, 2021
Purpose: Many intraocular pressure (IOP)-lowering medications contain benzalkonium chloride (BAK), a preservative associated with unfavorable outcomes.
A. Halder, A. Khopade
semanticscholar   +1 more source

Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2

open access: yesAdvances in Therapy, 2020
Introduction New open-angle glaucoma (OAG) and ocular hypertension (OHT) therapies that reduce treatment burden and improve outcomes relative to currently available agents are needed.
S. Asrani   +7 more
semanticscholar   +1 more source

Peripheral Latanoprost Administration Lowers Intraocular Pressure in the Wistar Rat

open access: yesOphthalmology and Therapy, 2020
Purpose Instillation of latanoprost eye drops into the conjunctival sac to lower intraocular pressure (IOP) is the most frequently used treatment for primary open-angle glaucoma.
Maciej Świątkiewicz   +5 more
doaj   +1 more source

Long-term cost and efficacy analysis of latanoprost versus timolol in glaucoma patients in Germany

open access: yesInternational Journal of Ophthalmology, 2013
AIM: To evaluate 5-year effectiveness and cost between latanoprost or timolol monotherapy in a pilot trial. METHODS: A retrospective, multi-center trial performed at 6 sites in Germany of patients who had a diagnosis of primary open-angle or ...
Jeanette A. Stewart   +6 more
doaj   +1 more source

Episcleral Venous Pressure and the Ocular Hypotensive Effects of Topical and Intracameral Prostaglandin Analogs. [PDF]

open access: yes, 2019
There is a limit beyond which increasing either the concentration of a prostaglandin analog (PGA) or its dosing frequency fails to produce increases in ocular hypotensive efficacy with topical dosing.
Alm   +36 more
core   +2 more sources

A Study of Iridectomy Histopathologic Features of Latanoprost- andNon–Latanoprost-Treated Patients [PDF]

open access: yesArchives of Ophthalmology, 2004
To examine the histopathologic features of iridectomy specimens from patients undergoing glaucoma surgery and to compare histologic abnormalities in a group of patients with a history of latanoprost therapy with those in a group of patients who had no history of prostaglandin therapy (controls).Iridectomy specimens and patient history forms were ...
Christine M. Damico   +7 more
openaire   +2 more sources

Topical prostaglandin analogues and conjunctival inflammation in uveitic glaucoma. [PDF]

open access: yes, 2012
A pilot study to determine whether topical prostaglandin analogues alter the expression of conjunctival inflammatory markers in patients with uveitic glaucoma.Prospective, single-masked case series of 20 patients with uveitis and secondary raised ...
Gurbaxani, A   +3 more
core   +1 more source

Ocular manifestations of Sturge–Weber syndrome: pathogenesis, diagnosis, and management [PDF]

open access: yes, 2016
Sturge-Weber syndrome has been included in the group of phakomatoses that is characterized by hamartomas involving the brain, skin, and eyes. The characteristic facial port-wine stain, involving the first branch of the trigeminal nerve and the embryonic ...
Abdolrahimzadeh, Solmaz   +4 more
core   +1 more source

Efficacy and safety of netarsudil/latanoprost fixed-dose combination vs. monotherapy in open-angle glaucoma or ocular hypertension: A systematic review and meta-analysis of randomized controlled trials

open access: yesFrontiers in Medicine, 2022
ObjectiveAs monotherapy is insufficient for some patients, the existing fixed-dose combination (FDC) requires two or more daily administrations with declining adherence.
Nachuan Luo   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy